Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C.
Loi S, et al. Among authors: jansen mp.
BMC Genomics. 2008 May 22;9:239. doi: 10.1186/1471-2164-9-239.
BMC Genomics. 2008.
PMID: 18498629
Free PMC article.